Test #2 Flashcards
Which of the following is not a common lymphatic field name for our breast cancer patients?
BCT
SCV
PAB
IMC
BCT
Triple negative breast cancers have a __________ prognosis.
worse
Which of the following is not a breast cancer receptor?
ER
MR
PR
HER2
MR
Select the following skin reactions that are common from radiation therapy treatment for breast cancer patients. (choose all that apply)
-Alopecia
-Hyper/Hypopigmentation
-Pruritis
-Dermatitis
-Alopecia
-Hyper/Hypopigmentation
-Pruritis
-Dermatitis
Which of the following is NOT a goal of breast conservation treatment?
Achieve uniformity in both the treated and the untreated breast
Dry desquamation may occur after ___________cGY.
40cGy
Describe briefly how brachytherapy, or accelerated partial breast irradiation (APBI), can be used to treat our patients with breast cancer. How does this treatment differ from EBRT?
One difference between EBRT and APBI is that EBRT is completely external. While APBI radioactive seeds mus be placed near to tumor internally. These seeds are placed close to the tumor where they kill cancerous cells.
What is the primary function of the respiratory system?
Exchange of gases
The left lung consists of ___ lobes; the right lung consists of ___ lobes.
2; 3
________________ is the only known risk factor for mesothelioma.
Asbestos
What is the only definitive way to diagnose lung cancer?
Biopsy
Which of the following are common side effects of radiation treatment for lung cancer? (3)
Esophagitis
Fatigue
Dyspnea
Non-small cell lung cancer is __________ common than small cell lung cancer.
more
Please explain how you, as a radiation therapist, would advise a lung cancer patient (and discuss this with the rad onc) to manage his/her symptoms throughout treatment. The patient is experiencing shortness of breath, especially when lying down on the table for treatment.
When a patient is experiencing these types of symptoms I would adivse them to speak to the nurse. If the patient is having too much trouble I might sugggest a different set up to the rad oncologist where the patients is not lying down flat.
Multiple tumor types are included in the head and neck region. Which type of primary tumor is most common?
Squamous cell carcinoma
Which of the following is not a main group for lymph nodes in the head and neck region?
-Facial group
-Submandibular group
-Extraglandular parotid group
-Cervical nodes
Cervical nodes
After what dose of radiation does xerostomia typically first occur?
1500 cGy
What is the most common presenting symptom of larynx cancer?
Hoarseness
Which of the following is not considered in the head and neck region when talking about cancer patients.
Brain
Treatment for head and neck cancer is the most dependent on ______________ and stage.
Tumor location
The pharynx consists of….. (choose all that apply).
oropharynx
nasopharynx
hypopharynx
Chemicals that enhance the lethal effects of radiation are known as ____________.
radiosensitizers
The 5-year survival of patients with glioblastoma multiforme (GBM) is:
22%
What is the most common type of brain tumor?
Metastatic brain lesions
What is the most common CNS tumor in children?
Medulloblastoma
Match the following presenting symptom to the location in the brain.
Frontal lobe
Parietal lobe
Occipital lobe
Cerebellum
Hypothalamus
Temporal lobe
- Mood disturbances
- Paralysis
- Loss of vision
- Loss of balance
- Emotional changes
- Perceptual/spatial disturbances
Which of the following is most significant to the prognosis of brain tumors?
Grade
What defines the inferior radiation field border for the treatment of the whole brain for palliation?
Superior orbital ridge
External auditory meatus
What is a grade IV astrocytoma called?
Glioblastoma
Explain why chemotherapy is not always effective in CNS patients.
Because of the blood brain barrier. This blocks chemotherapy from reaching its target.
How many lobes in left breast?
2
What is the most common breast brachytherapy device called?
SAVI
What are the three hormone receptors commonly tested for breast cancer patients?
Estrogen receptor,
Progesterone receptor,
HER2
